Navigation Links
Engineer develops detergent to promote peripheral nerve healing
Date:6/10/2008

AUSTIN, Texas A detergent solution developed at The University of Texas at Austin that treats donor nerve grafts to circumvent an immune rejection response has been used to create acellular nerve grafts now used successfully in hospitals around the country. Research also shows early promise of the detergent solution having possible applications in spinal cord repair.

The solution combined with an enzyme treatment conceived at the University of Florida in Gainesville is licensed by AxoGen, an Alachua, Florida-based company, and is used to create an acellular nerve graft from human cadaver tissue, called AVANCE Nerve Graft. Nationwide, nearly 100 patients suffering nerve injuries have received AVANCE grafts, all involving peripheral nerves which transmit sensory information between the brain and muscles.

Christine Schmidt, a biomedical engineering professor, developed the detergent solution in her lab with Terry Hudson and Curt Deister, chemical engineering graduate students at the time, who are now with Genentech in California and with AxoGen, respectively.

"Surgeons are reporting some early successes," she says.

These grafts are being used to treat people with traumatic injuries potentially resulting from lacerations, gunshots and everyday accidents, but it also has been used to treat cavernous nerves after the removal of the prostate. The AVANCE product has treated wounded soldiers and can treat the nerves in hands, arms, legs and the face.

Traditional treatment of these types of nerve trauma required harvesting an intact nerve from the patient's body and transplanting it to repair the damaged area. However, that requires two surgeries, is more costly and leads to loss of nerve function and possible infection at the donor nerve site, Schmidt says.

Synthetic, tubular grafts are another surgery repair option. However, Schmidt says they are limited to repairing very small injuries. She adds AVANCE nerve grafts are able to bridge long nerve gaps, provide a three-dimensional pathway supporting nerve regeneration and are easily bendable because they are human nerve harvested from tissue donors, making it easier for surgeons to handle.

"This method has broader applicability," Schmidt says. "Formerly a patient's only option was to use their own nerve or the completely synthetic grafts."

By using the detergent solution, the donor nerve is stripped of the cellular lipid components, which causes the immune rejection response when implanted. Schmidt's laboratory spent four years developing the solution to be strong enough to remove rejection-inducing factors, but mild enough to preserve the delicate physical architecture of the nerve essential for regeneration. The resulting tolerated transplanted nerve provides a type of scaffolding that serves as a bridge between the two ends of the severed nerve to promote regrowth. And because the immunogenic lipid components have been extracted, patients don't require immunosuppressant drugs.

AxoGen learned about the detergent processing work in Schmidt's lab, licensed it and combined it with the University of Florida enzyme treatment that removes other regrowth inhibiting factors, creating the AVANCE product.

"So they've taken something from our lab that works really well and made it work even better," Schmidt says.

Schmidt now is conducting spinal-cord lab testing in animals using detergent-treated peripheral nerve grafts. She is working with post-doctoral fellow Zin Khaing, a central nervous system expert.


'/>"/>

Contact: Christine Schmidt
schmidt@che.utexas.edu
512-471-1690
University of Texas at Austin
Source:Eurekalert

Related biology news :

1. bioMETRX Expands Engineering and Manufacturing Capabilities
2. IEEE Fellow first woman to receive highest award in engineering profession
3. NJIT Provost Priscilla P. Nelson honored at National Academy of Engineering
4. Engineer to spearhead research into cell metabolism and medical injuries
5. Prof. David Kisailus studies engineering and invention on the half-shell
6. McMaster University engineering professor receives Humboldt Research Award
7. Genetic Engineering & Biotechnology News reports on growing use of cell-based assays
8. Genetic Engineering & Biotechnology News reports on cancer biomarkers
9. Brown hosts regional bioengineering conference
10. Scientists find that squid beak is both hard and soft, a material that engineers want to copy
11. Small desert beetle found to engineer ecosystems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... Research and Markets has announced the addition ... Trends - Industry Forecast to 2025" report to their offering. ... The Global Biometric ... of around 15.1% over the next decade to reach approximately $1,580 ... market estimates and forecasts for all the given segments on global ...
(Date:3/22/2017)... , March 21, 2017   Neurotechnology , ... recognition technologies, today announced the release of the ... which provides improved facial recognition using up to ... a single computer. The new version uses deep ... accuracy, and it utilizes a Graphing Processing Unit ...
(Date:3/20/2017)... , March 20, 2017 At this year,s ... -based biometrics manufacturer DERMALOG. The Chancellor came to the DERMALOG stand ... is this year,s CeBIT partner country. At the largest German biometrics ... in use: fingerprint, face and iris recognition as well as DERMALOG´s multi-biometrics ... ...
Breaking Biology News(10 mins):
(Date:3/24/2017)... Ltd. ("Sinovac" or the "Company") (NASDAQ: SVA), a leading provider of ... its board of directors has amended its shareholder rights plan. The amendment ... to March 27, 2018. The amendment was not in response to any ... ... is a China -based biopharmaceutical company that focuses ...
(Date:3/23/2017)... ... , ... Lajollacooks4u is proud to announce it has become the premiere team-building cooking event company ... around the world, such as Illumina, HP and Qualcomm, and is ranked #1 in its ... is due to its new team building format, a way for teams to not only ...
(Date:3/23/2017)... 2017  BioPharmX Corporation (NYSE MKT: BPMX), a ... market, today reported financial results for the quarter ... provide an update on the company,s clinical development ... "We are pleased to report that last year ... President Anja Krammer. "We achieved key clinical milestones ...
(Date:3/23/2017)... 2017  Agriculture technology company Cool Planet has closed ... conversion to commercialize its Cool Terra and Cool Fauna ... products that are simultaneously profitable as well as sustainable ... 18 months. This latest round of funding was led ... The company,s primary product, Cool Terra, can ...
Breaking Biology Technology: